Efficacy and safety of telmisartan monotherapy in the black hypertensive patient at a tertiary centre in Eastern Nigeria
Background: The prevalence of hypertension is increasing globally, and is higher in black patients. In Nigeria the estimated prevalence is 17.6% and affects about 21 million people. End organ damage associated with hypertension is more prevalent and more severe in black patients. Adequate control of...
Main Authors: | C K Ijoma, I I Ulasi, U N Ijoma |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | International Journal of Medicine and Health Development |
Subjects: | |
Online Access: | http://www.ijmhdev.com/article.asp?issn=2635-3695;year=2011;volume=16;issue=1;spage=17;epage=23;aulast=Ijoma;type=0 |
Similar Items
-
TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01) -
Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01) -
Central blood pressure lowering effect of telmisartan‐rosuvastatin single‐pill combination in hypertensive patients combined with dyslipidemia: A pilot study
by: JungMin Choi, et al.
Published: (2021-09-01) -
Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats
by: Chang Ho Lee, et al.
Published: (2021-11-01) -
ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-07-01)